Skip to content

Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07558395
Acronym
REVIIH-BT
Enrollment
120
Registered
2026-04-30
Start date
2026-05-15
Completion date
2029-09-01
Last updated
2026-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemianopsia, Virtual Reality, Visual Rehabilitation, Pediatric Brain Tumor

Keywords

brain tumor, pediatric, visual rehabilitation, virtual reality

Brief summary

Evaluate the efficiency of audiovisual stimulation in virtual reality for improving the visual perception of children, adolescents, and young adults with hemianopia resulting from pediatric brain tumors. These individuals can lose up to 50% of their visual field, significantly impacting their independence, mobility, and daily lives.

Interventions

Our audiovisual stimulation procedure IVR, called 3D-MOT, was encoded using the the 3D Unity programming platform and deployed in HMDs with built-in head/eye tracking. We implemented the multiple object tracking (MOT) paradigm, developed in the 80's to study visual attention in humans, and added correlated spatial sound.

OTHERstandard of care

During this phase, the patients will be at home without a headset and will not be exposed to an audio-visual stimulation task in virtual reality.

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV
Fight Kids Cancer
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Intervention model description

We will perform a phase IIb, single blind (to assessor), prospective, randomized, controlled, multicentric, delayed-start, parallel-group study.

Eligibility

Sex/Gender
ALL
Age
10 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Male and Female * 10 - 40 years old * Diagnosed hemianopsia (\>12 months) * History of diagnosis brain tumour * Being stable for the tumour for \> 6 months (either on therapy or not) * Visual acuity ≤ 0.7 LogMAR * Ability to follow the visual and auditory stimuli and training instructions * Home WiFi access * Ability to attend all on site visits * Affiliation to the Social Security or beneficiary of such social protection

Exclusion criteria

* Age\< 10 years old of \> 40 years old * Ocular disease * Inability to perform during testing or training * 3 consecutive VRISE scores \< 25 at inclusion * History of vertigo * Prior vision rehabilitation interventions * Recreational or medicinal consumption of psychoactive drugs * Persons under court protection * Interpupillary distance \< 54mm

Design outcomes

Primary

MeasureTime frameDescription
Visual field perimetry measured using the Esterman binocular field testFrom enrollment to the end of follow up period at 6 monthsIncrease at least 3 points in the number of points perceived in the blind field at the Esterman binocular field test after intervention (8 weeks) when compared to baseline and between control and interventional group.

Secondary

MeasureTime frameDescription
Participant-reported a vision impairment specific quality of life questionnaire: Impact of Vision Impairment Questionnaire (IVI).From enrollment to the end of follow up period at 6 monthsQuestionnaire will be provided and compared at baseline and after intervention ( 8 weeks) and between control and interventional group. A diminution of the mean score above 0.3-0.5 point will be consider as an amelioration of quality of life impacted by vision impairment.
Reading speed - Minnesota Low Vision Reading (MNREAD) testFrom enrollment to the end of follow up period at 6 monthsReading speed will be assessed and compared at baseline and after intervention (8 weeks) and between control and interventional groups. An increase in reading speed of 8.6 words per minute on the Minnesota Low Vision Reading (MNREAD) test will be considered an improvement in the variable.

Countries

Austria, Denmark, France, Italy, Netherlands, Spain, United Kingdom

Contacts

CONTACTMichael Reber, PhD
michael.reber@inserm.fr+33 388116648
CONTACTNatacha Entz-Werle, Pr
Natacha.Entz-Werle@chru-strasbourg.fr0388128396

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 1, 2026